The majority of research demonstrated a higher plasma complement C3 level correlated with more brain amyloid burden [26, 27] and less hippocampal volume [28] in sporadic AD [29] and mutation carriers of autosomal dominant form of AD [30]. This evidence concerns the gene C3 and Alzheimer disease.